Melanocortin pathway
Studied as an agonist of the melanocortin receptors (MC1R to MC4R), a signalling family linked to pigmentation, appetite and sexual response.
PT-141 Bali supplies genuine, research-grade PT-141 (Bremelanotide), in lyophilised vials and pre-measured nasal spray, with discreet same-day cold-chain delivery and simple WhatsApp ordering.
PT-141 (Bremelanotide) is a synthetic cyclic peptide that acts as a non-selective agonist of the melanocortin receptors, primarily MC1R and MC4R.
Unlike vascular approaches that act on blood flow, PT-141 is studied for a central nervous system mechanism, which is why it draws interest across libido and sexual-function research models. Bremelanotide was originally derived from the peptide Melanotan II.
PT-141 Bali supplies the compound in two research formats so labs can match it to their protocol. Everything we ship is for laboratory research use only.
Studied as an agonist of the melanocortin receptors (MC1R to MC4R), a signalling family linked to pigmentation, appetite and sexual response.
Investigated in libido and sexual-function research models in both directions, the use case bremelanotide is best known for.
Examined for a central, CNS-mediated mechanism that is distinct from peripheral, vascular research approaches.
We focus on what we can stand behind: a genuine, research-grade compound, careful cold-chain handling, and fast, discreet delivery across Bali.
Research-use pricing, current June 2026. Confirm the latest stock and price on WhatsApp.
Standard lyophilised research vial. Reconstitute with bacteriostatic water for flexible measuring across protocols.
Pre-measured research nasal spray. Arrives ready to use, with no reconstitution and no measuring.
Prices in Indonesian Rupiah · Payment on delivery confirmation · Nationwide shipping available
Both deliver the same 10mg of research-grade PT-141. The difference is preparation, flexibility and convenience.
| Attribute | 10mg Lyophilised Vial | 10mg Nasal Spray |
|---|---|---|
| Preparation | Reconstitute with bacteriostatic water | Pre-measured, ready to use |
| Measuring flexibility | High, set your own volumes | Fixed per actuation |
| Shelf form | Stable lyophilised powder | Solution |
| Equipment needed | Bacteriostatic water, syringe | None |
| Best for | Flexible, precise research protocols | Convenience & repeatability |
| Price (IDR) | 1,500,000 | 2,500,000 |
Research-grade PT-141 sourced for purity and batch-to-batch consistency you can plan a study around.
Same-day, discreet, cold-chain delivery across Bali (villa, clinic or lab) in plain, unmarked packaging.
Clear WhatsApp guidance on reconstitution, storage and handling, before and after your order arrives.
Tell us the format you want and your area in Bali. We confirm current stock, price and delivery window.
Discreet, cold-chain delivery to your door across Bali, usually within a few hours. Payment on confirmation.
Guidance on reconstitution and storage whenever you need it. We stay reachable after the handover.
Fast, discreet delivery to Seminyak and great communication throughout.
Genuine product, well packaged, and quick to answer my questions on WhatsApp.
Reliable service and same-day delivery. Exactly what was described.
| Compound | PT-141 (Bremelanotide) |
|---|---|
| Class | Melanocortin receptor agonist |
| Format | Lyophilised vial / research nasal spray |
| Strength | 10mg |
| Purity | 99%+ research-grade |
| Storage | Cool, dark; refrigerate after reconstitution |
| Reconstitution | Bacteriostatic water (vial) |
| Delivery | Same-day across Bali; nationwide shipping |
| Intended use | Laboratory & research only |
In 2004, researchers led by L. E. Diamond published one of the first human studies of PT-141 in the International Journal of Impotence Research. The trial gave intranasal PT-141 to healthy men and to men with mild to moderate erectile dysfunction who had not responded well to sildenafil, and it set the direction for much of the research that followed. The study was double blind and placebo controlled, and its main focus was safety, pharmacokinetics and pharmacodynamic effects rather than a single efficacy outcome.
PT-141, known chemically as bremelanotide, is studied as a non-selective agonist of the melanocortin receptors, mainly MC1R and MC4R. Researchers looking at PT-141 in Bali are usually interested in this central nervous system mechanism, distinct from approaches that work on blood vessels directly. A 2007 review by Pfaus and colleagues in the Journal of Sexual Medicine gathered the preclinical, animal based evidence for that central pathway and its link to female sexual function research.
The trials that followed moved from men to premenopausal women with hypoactive sexual desire disorder. Two phase 3 studies published in 2019 by Kingsberg and colleagues in Obstetrics and Gynecology, run under the name RECONNECT, tested self administered bremelanotide in this group. That research program led to US approval of the branded product later in 2019, recorded the same year in a review by Dhillon and Keam in the journal Drugs. The compound supplied here is the same bremelanotide studied in that literature, provided for laboratory and research use rather than as the approved medicine.
Researchers choosing between formats are really choosing between preparation styles. The lyophilised vial is a powder that needs reconstituting with bacteriostatic water, which allows for flexible measuring across a protocol. The nasal spray arrives pre measured, so there is no reconstitution step, trading that flexibility for convenience. Some protocols favour the vial specifically because the reconstituted concentration can be adjusted, while others favour the spray because it removes a preparation step entirely.
Both formats need to stay cool and out of direct light before use. Once a vial has been reconstituted, it belongs in the refrigerator and should be used inside the compound's usual stability window rather than left at room temperature between sessions. The nasal spray, already in solution, should also be kept refrigerated once opened and away from heat, since it does not go through the same lyophilised storage stage as the vial.
No. The approved product is a specific branded formulation, manufactured and packaged for a defined medical use under regulatory oversight. What is supplied here is the same active compound, bremelanotide, provided in research formats for laboratory and research use, not as that approved, prescription only medicine.
No, though it is related. Bremelanotide was developed from Melanotan II and is studied for a different receptor and mechanism profile, chiefly as an MC1R and MC4R agonist, rather than the melanogenesis and tanning focus more commonly associated with Melanotan II research.
RECONNECT was the name given to two phase 3 trials of bremelanotide in premenopausal women, published by Kingsberg and colleagues in Obstetrics and Gynecology in 2019. The trials examined a self administered, on demand dose and formed the basis for the branded product's eventual approval.
Yes. Early published research, including a 2004 study by Diamond and colleagues, tested intranasal PT-141 in healthy men and in men with erectile dysfunction who had not responded well to sildenafil. Later, larger trial programs then shifted focus to premenopausal women with hypoactive sexual desire disorder.
Because the melanocortin receptors PT-141 acts on sit in the central nervous system rather than in blood vessel walls. Researchers have studied this as a mechanistic difference from vascular approaches used elsewhere in sexual function research, not as a claim about comparative outcomes or effectiveness.
The fastest answer is a message away. We confirm stock, price and delivery in real time.
Ask on WhatsAppPT-141, also known as Bremelanotide, is a synthetic cyclic peptide that acts as a non-selective agonist of the melanocortin receptors, primarily MC1R and MC4R. It is studied in libido, sexual-function and central-nervous-system research, and is supplied for laboratory research use only.
Two formats: a standard 10mg lyophilised research vial reconstituted with bacteriostatic water, and a pre-measured 10mg research nasal spray that requires no reconstitution.
Message us on WhatsApp at +62 878-6915-5538 with the format and your Bali location. We confirm stock, price and delivery, with payment on confirmation.
Same-day across most of Bali, usually within a few hours. Nationwide shipping from Bali across Indonesia is also available.
Keep it cool and out of direct light. After reconstitution with bacteriostatic water, refrigerate at 2–8°C and use within the compound's typical stability window.
With bacteriostatic water, added slowly down the side of the vial and gently swirled until dissolved. We can guide you through the full process on WhatsApp.
The vial is lyophilised powder reconstituted with bacteriostatic water, offering flexible measuring for research protocols. The nasal spray arrives pre-measured and ready to use with no reconstitution, trading flexibility for convenience.
No. It is supplied strictly for laboratory and research purposes, not for human or veterinary use, and nothing on this site constitutes medical advice.
Nationwide shipping from Bali across Indonesia also available. Just ask on WhatsApp.
Message PT-141 Bali on WhatsApp for current stock, pricing and same-day delivery across the island.
Order on WhatsApp